<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38041762</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8491</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>European archives of psychiatry and clinical neuroscience</Title><ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>All eyes on PCS: analysis of the retinal microvasculature in patients with post-COVID syndrome-study protocol of a 1&#xa0;year prospective case-control study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-023-01724-5</ELocationID><Abstract><AbstractText>Since widespread vaccination against COVID-19, the development of effective antiviral drugs, and the decreasing number of patients with COVID-19 in intensive care, the risk from SARS-CoV-2 infection appears less threatening. However, studies show that a significant number of patients suffer from long-term sequelae, even months after SARS-CoV-2 infection. The so-called post-COVID syndrome (PCS) often presents a diagnostic and treatment challenge for physicians. This study protocol describes the "All Eyes on PCS" study, which aims to investigate the retinal microvasculature in PCS patients and COVID-19-recovered patients to provide new insights into the pathophysiology of PCS. "All Eyes on PCS" is a prospective, case-control study with the primary objective of detecting endothelial dysfunction (ED) in patients with PCS. Therefore, we intend to recruit patients with PCS, fully SARS-CoV-2-infection-recovered (CR) participants, and SARS-CoV-2-infection-na&#xef;ve (CN) participants. Baseline measurements will include: (1) patient-specific characteristics, (2) biochemistry, (3) retinal vessel analysis (RVA), (4) survey questionnaires as patient-reported outcomes measurements (PROMs), (5) optical coherence tomography (OCT), OCT angiography (OCTA), and adaptive optics (AO), (6) blood pressure recordings, (7) handgrip strength test. After 6 months, baseline measurements will be repeated in the PCS cohort, and after 1 year, a telephone query will be conducted to assess residual symptoms and treatment needs. The aim of this study is to gain insight into the pathophysiology of PCS and to provide an objective biomarker for diagnosis and treatment, while also creating a comprehensive clinical database of PCS patients.ClinicalTrials.gov Identifier: NCT05635552; Date: 2.12.2022.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuchler</LastName><ForeName>Timon</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0006-4499-1223</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. timon.kuchler@mri.tum.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hausinger</LastName><ForeName>Renate</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braunisch</LastName><ForeName>Matthias C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nthner</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wicklein</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knier</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bleidi&#xdf;el</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribero</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medizinische Klinik und Poliklinik IV, LMU University Hospital Munich, Ziemssenstra&#xdf;e 5, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lech</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medizinische Klinik und Poliklinik IV, LMU University Hospital Munich, Ziemssenstra&#xdf;e 5, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adorjan</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital Munich, Nu&#xdf;baumstra&#xdf;e 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stubbe</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medizinische Klinik und Poliklinik II, LMU University Hospital Munich, Marchioninistra&#xdf;e 15, 81377, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotilar</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aachen University of Applied Sciences, Heinrich-Mussmann-Str. 1, 52428, J&#xfc;lich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heemann</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmaderer</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. Christoph.schmaderer@mri.tum.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05635552</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>H.4001.1.7-53/7</GrantID><Agency>Bayerisches Staatsministerium f&#xfc;r Bildung und Kultus, Wissenschaft und Kunst</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA><NlmUniqueID>9103030</NlmUniqueID><ISSNLinking>0940-1334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Retinal microvasculature</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>2</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>2</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>2</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38041762</ArticleId><ArticleId IdType="doi">10.1007/s00406-023-01724-5</ArticleId><ArticleId IdType="pii">10.1007/s00406-023-01724-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tang D, Comish P, Kang R (2020) The hallmarks of COVID-19 disease. PLoS Pathog 16(5):e1008536</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008536</ArticleId><ArticleId IdType="pubmed">32442210</ArticleId><ArticleId IdType="pmc">7244094</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC et al (2020) Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 116(14):2177&#x2013;2184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa230</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Montiel V et al (2022) Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients. EBioMedicine 77:103893</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103893</ArticleId><ArticleId IdType="pubmed">35219085</ArticleId><ArticleId IdType="pmc">8865837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D et al (2020) Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med 173(4):268&#x2013;277</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417&#x2013;1418</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId><ArticleId IdType="pmc">7172722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z et al (2022) Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 164:69&#x2013;82</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.11.010</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203(2):631&#x2013;637</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId><ArticleId IdType="pmc">7167720</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M-Y et al (2020) Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 9(1):45</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId><ArticleId IdType="pmc">7186534</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L et al (2021) Expression of the SARS-CoV-2 Receptor ACE2 in Human Retina and Diabetes-Implications for Retinopathy. Invest Ophthalmol Vis Sci 62(7):6</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.62.7.6</ArticleId><ArticleId IdType="pubmed">34086044</ArticleId><ArticleId IdType="pmc">8185397</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo-Silva CA et al (2021) Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19. JAMA Ophthalmol 139(9):1015&#x2013;1021</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2021.2795</ArticleId><ArticleId IdType="pubmed">34323931</ArticleId><ArticleId IdType="pmc">8323055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo GJ et al (2021) Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann Diagn Pathol 51:151682</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151682</ArticleId><ArticleId IdType="pubmed">33360731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y et al (2021) SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2. Circ Res 128(9):1323&#x2013;1326</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId><ArticleId IdType="pmc">8091897</ArticleId></ArticleIdList></Reference><Reference><Citation>Urata R et al (2022) Senescent endothelial cells are predisposed to SARS-CoV-2 infection and subsequent endothelial dysfunction. Sci Rep 12(1):11855</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15976-z</ArticleId><ArticleId IdType="pubmed">35879338</ArticleId><ArticleId IdType="pmc">9314328</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R, Enjyoji K, Schmaier AA (2022) Vasculopathy in COVID-19. Blood 140(3):222&#x2013;235</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId><ArticleId IdType="pmc">8736280</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27(4):601&#x2013;615</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="pmc">8893149</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB et al (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22(4):e102&#x2013;e107</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV et al (2022) Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. The Lancet 400(10350):452&#x2013;461</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayet S et al (2021) Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comt&#xe9; Hospital, France. Microorganisms 9(8):1719</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081719</ArticleId><ArticleId IdType="pubmed">34442798</ArticleId><ArticleId IdType="pmc">8401026</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau A-F et al (2021) Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann Intensive Care 11(1):118</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00910-9</ArticleId><ArticleId IdType="pubmed">34324073</ArticleId><ArticleId IdType="pmc">8319705</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H et al (2021) Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost 19(10):2546&#x2013;2553</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M et al (2021) Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging 48(5):1460&#x2013;1466</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C et al (2022) Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol 12:861703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId><ArticleId IdType="pmc">9016198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C et al (2022) A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun 13(1):5104</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId><ArticleId IdType="pmc">9426365</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M et al (2022) Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med 20(1):138</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId><ArticleId IdType="pmc">8938726</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rland K et al (2021) Reduced endothelial function in myalgic encephalomyelitis/chronic fatigue syndrome-results from open-label cyclophosphamide intervention study. Front Med 8:642710</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.642710</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M et al (2022) The immunology and immunopathology of COVID-19. Science 375(6585):1122&#x2013;1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D et al (2022) Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 54(1):1473&#x2013;1487</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId><ArticleId IdType="pmc">9132392</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C, Collins LF, Malani P (2020) Long-term Health Consequences of COVID-19. JAMA 324(17):1723&#x2013;1724</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId><ArticleId IdType="pmc">8019677</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E et al (2022) Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study. Vascul Pharmacol 144:106975</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId><ArticleId IdType="pmc">8893931</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B et al (2021) Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Med (Lausanne) 8:676554</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.676554</ArticleId><ArticleId IdType="pubmed">34307408</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S et al (2021) Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study. Front Cardiovasc Med 8:745758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId><ArticleId IdType="pmc">8670225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim M et al (2013) Systemic associations of dynamic retinal vessel analysis: a review of current literature. Microcirculation 20(3):257&#x2013;268</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/micc.12026</ArticleId><ArticleId IdType="pubmed">23151190</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nthner R et al (2019) Impaired Retinal Vessel Dilation Predicts Mortality in End-Stage Renal Disease. Circ Res 124:1796</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.314318</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidelmann SB et al (2016) Retinal Vessel Calibers in Predicting Long-Term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study. Circulation 134(18):1328&#x2013;1338</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.023425</ArticleId><ArticleId IdType="pubmed">27682886</ArticleId><ArticleId IdType="pmc">5219936</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB et al (1988) Fatigue in Multiple Sclerosis. Arch Neurol 45(4):435&#x2013;437</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1988.00520280085020</ArticleId><ArticleId IdType="pubmed">3355400</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL et al (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166(10):1092&#x2013;1097</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM et al (2003) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Chronic Fatigue Syndrome 11(1):7&#x2013;115</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606&#x2013;613</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId><ArticleId IdType="pmc">1495268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampiccoli E et al (2022) Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis. ESC Heart Fail 9(2):1186&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13792</ArticleId><ArticleId IdType="pubmed">35060356</ArticleId><ArticleId IdType="pmc">8934987</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;gele MP et al (2018) Retinal microvascular dysfunction in heart failure. Eur Heart J 39(1):47&#x2013;56</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx565</ArticleId><ArticleId IdType="pubmed">29069316</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>